Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
Stocks
Immunovant, Inc.
Business Segments
Business Segments
Acquired in-process research and development
Acquired in-process research and development
Immunovant, Inc.
·
Business Segments
·
1 segment
·
Rolls up to
Acquired in-process research and development
Breakdown
Segments
Business Segments
View metric
Watchlist
Screener
Filings
Earnings
Charts
Annual
Segment
FY'25
FY'26
Business Segments
$0
$0
Total
—
—
All segment values are derived from annual filings.
